Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
10.1.2025 09:51:37 CET | Demant A/S | Managers' Transactions
Company announcement no 2025-01 | 10 January 2025 |
Transactions with Demant shares by managers and closely related parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Søren Nielsen |
2. | Reason for the notification | |
a) | Position/status | President & CEO |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 299 shares DKK 362.42 per share 289 shares DKK 326.63 per share 321 shares DKK 327.08 per share 331 shares DKK 330.41 per share 328 shares DKK 298.46 per share 363 shares DKK 260.28 per share 416 shares DKK 286.14 per share 379 shares DKK 263.42 per share 411 shares DKK 261.77 per share 414 shares DKK 275.00 per share 394 shares DKK 280.81 per share 386 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 4,331 shares Price: DKK 1,290,172.78 |
e) | Date of the transaction | 8 January 2025 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | René Schneider |
2. | Reason for the notification | |
a) | Position/status | CFO |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 71 shares DKK 362.42 per share 97 shares DKK 326.63 per share 93 shares DKK 327.08 per share 95 shares DKK 330.41 per share 94 shares DKK 298.46 per share 104 shares DKK 260.28 per share 121 shares DKK 286.14 per share 110 shares DKK 263.42 per share 100 shares DKK 261.77 per share 101 shares DKK 275.00 per share 96 shares DKK 280.81 per share 94 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 1,176 shares Price: DKK 352,068.76 |
e) | Date of the transaction | 8 January 2025 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Niels Wagner |
2. | Reason for the notification | |
a) | Position/status | President of Hearing Care |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 173 shares DKK 362.42 per share 167 shares DKK 326.63 per share 187 shares DKK 327.08 per share 198 shares DKK 330.41 per share 196 shares DKK 298.46 per share 217 shares DKK 260.28 per share 249 shares DKK 286.14 per share 226 shares DKK 263.42 per share 246 shares DKK 261.77 per share 247 shares DKK 275.00 per share 235 shares DKK 280.81 per share 231 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 2,572 shares Price: DKK 765,074.91 |
e) | Date of the transaction | 8 January 2025 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
Further information: Peter Pudselykke, Head of Investor Relations Maribel Alonso Francisco, Communication Advisor
Phone +45 3917 7300 |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.